Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jun;43(6):809–816. doi: 10.1038/bjc.1981.119

Antitumour antibodies induced by rat embryo cells and spontaneous mammary carcinoma cells treated with 3-methylcholanthrene.

J G Reeve, M J Embleton, R W Baldwin
PMCID: PMC2010702  PMID: 7018549

Abstract

It has previously been shown that rat embryo cells treated in vitro with 3-methylcholanthrene (MCA) elicit antibodies in syngeneic rats which react specifically against established MCA-induced sarcomas. To examine the possibility that clonal amplification of one or a few antigenic, preneoplastic clones is responsible for the previously observed specific antibody responses, MCA-treated rat embryo cells have been subjected to 150 Gy of gamma-irradiation before injection into host animals. The resulting antisera were screened for reactivity against a panel of established syngeneic tumours by membrane immunofluorescence and an isotopic antiglobulin test. A positive reaction was observed between an antiserum pool raised against gamma-irradiated MCA-treated cells and the cells of an immunogenic spontaneous mammary carcinoma. Antiserum to gamma-irradiated control (acetone-treated) cells was negative. Thus gamma-irradiation of carcinogen-treated cells before injection failed to abolish specific antibody responses in immunized rats. To investigate further the relationships between cell-carcinogen interaction, neoantigen induction and malignancy, the cells of a non-immunogenic, spontaneous mammary carcinoma were treated with MCA in vitro, and antisera against treated and untreated cells were tested against a panel of established tumours. A positive membrane-immunofluorescence reaction was obtained with an antiserum to MCA-treated cells, but not to untreated cells against an aminoazodye-induced hepatoma, indicating that the previously non-immunogenic mammary carcinoma cells had acquired new antigenic specificities as a consequence of carcinogen treatment.

Full text

PDF
809

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin R. W., Barker C. R., Embleton M. J., Glaves D., Moore M., Pimm M. V. Demonstration of cell-surface antigens on chemically induced tumors. Ann N Y Acad Sci. 1971 Jun 21;177:268–278. doi: 10.1111/j.1749-6632.1971.tb35056.x. [DOI] [PubMed] [Google Scholar]
  2. Baldwin R. W., Embleton M. J. Immunology of spontaneously arising rat mammary adenocarcinomas. Int J Cancer. 1969 Jul 15;4(4):430–439. doi: 10.1002/ijc.2910040408. [DOI] [PubMed] [Google Scholar]
  3. Diamond L., Sardet C., Rothblat G. H. The metabolism of 7,12-dimethylbenz(a)anthracene in cell cultures. Int J Cancer. 1968 Nov 15;3(6):838–849. doi: 10.1002/ijc.2910030617. [DOI] [PubMed] [Google Scholar]
  4. Embleton M. J., Baldwin R. W. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells. Int J Cancer. 1979 Jun 15;23(6):840–845. doi: 10.1002/ijc.2910230616. [DOI] [PubMed] [Google Scholar]
  5. Embleton M. J., Heidelberger C. Antigenicity of clones of mouse prostate cells transformed in vitro. Int J Cancer. 1972 Jan 15;9(1):8–18. doi: 10.1002/ijc.2910090103. [DOI] [PubMed] [Google Scholar]
  6. Embleton M. J., Heidelberger C. Neoantigens on chemically transformed cloned C3H mouse embryo cells. Cancer Res. 1975 Aug;35(8):2049–2055. [PubMed] [Google Scholar]
  7. Hewitt H. B., Blake E. R., Walder A. S. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin. Br J Cancer. 1976 Mar;33(3):241–259. doi: 10.1038/bjc.1976.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lappé M. A. Tumour specific transplantation antigens: possible origin in pre-malignant lesions. Nature. 1969 Jul 5;223(5201):82–84. doi: 10.1038/223082a0. [DOI] [PubMed] [Google Scholar]
  9. Mondal S., Embleton M. J., Marquardt H., Heidelberger C. Production of variants of decreased malignancy and antigenicity from clones transformed in vitro by methylcholanthrene. Int J Cancer. 1971 Nov 15;8(3):410–420. doi: 10.1002/ijc.2910080308. [DOI] [PubMed] [Google Scholar]
  10. Williams A. F., Galfrè G., Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 1977 Nov;12(3):663–673. doi: 10.1016/0092-8674(77)90266-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES